Daewoong-Pharma
Scope
Date
~
-
Bio & Pharma
Boryung Pharma's sales surpass $311 mn in H1 2023
South Korea’s Boryung Corp. has alleviated the fear of falling behind in its sector expressed by its third-generation chairman Jay Kim Jung-Gy...
Jul 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Kolon Pharma, Dongbang Medical to export medical threads to Brazil
Kolon Pharma, the pharmaceutical affiliate of South Korea's Kolon Group, announced on Thursday that it has signed a business agreement with Dongbang...
Jul 27, 2023 (Gmt+09:00)
-
Logistics
CJ Logistics to enter global pharmaceutical transportation market
South Korea’s CJ Logistics on Wednesday said it obtained the certification CEIV Pharma, or the Center of Excellence for Independent Validators...
Jul 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong's Nabota exceeds 600,000 customers in US
South Korea's Daewoong Pharmaceutical said on Thursday that its local loyalty program for Nabota (American name: Jeuveau) in the US, a botulinum tox...
Jul 13, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma unveils S.Korea's first homegrown hybrid incubator
South Korea's JW Pharmaceutical on Wednesday released three products from its new incubator brand Hi-Mammi.The company's rollout of hybrid and high-...
Jun 29, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea’s top pharmaceutical distributor buys 25% of No. 2 Baekje Pharma
South Korea’s top pharmaceutical distributor Geo-young Co. has acquired 25% of market No. 2 Baekje Pharmaceutical.Geo-young on Tuesday said th...
Jun 14, 2023 (Gmt+09:00)
-
Bio & Pharma
HanAll, Daewoong to develop Parkinson's treatment with US partner
South Korea's HanAll Biopharma Co. and Daewoong Pharmaceutical on Thursday said they concluded a contract with NurrOn Pharmaceuticals of the US on...
May 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharmaceutical’s cumulative tech exports exceed $870 mn
South Korea’s Daewoong Pharmaceutical said on Friday that it had concluded three technology export agreements for new drugs and new drug candi...
May 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma to build third botulinum toxin plant for $746 mn
South Korea’s Daewoong Pharmaceutical next year will open a third plant to greatly expand annual output of its botulinum toxin Nabota at a cos...
May 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong to transfer techs for autoimmune disease to US pharma
South Korea's Daewoong Pharmaceutical announced on Friday that it has signed a technology export contract for the clinical development and commercia...
Apr 28, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Kainos Medicine exports AIDS treatment technology to China
South Korean new drug developer Kainos Medicine Inc. announced on Friday that it had signed a technology transfer agreement with Chinese pharmaceuti...
Apr 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma, UK firm to jointly develop autoimmune disease drug
South Korean drugmaker Daewoong Pharmaceutical Co. said on Tuesday that it has signed a cooperation agreement with Sygnature Discovery, a British ne...
Apr 18, 2023 (Gmt+09:00)
-
Private equity
MBK Partners co-founder tops 50 richest S.Koreans: Forbes
Michael ByungJu Kim, co-founder and partner at private equity firm MBK Partners, has topped the ranking of the 50 richest South Koreans by net worth...
Apr 18, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to use zebrafish in new drug development
South Korean drug developer JW Pharmaceutical has entered into a memorandum of understanding (MOU) with Zefit, a domestic non-clinical trial institu...
Apr 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics, Excellgene to collaborate on CDO biz
Lotte Biologics, South Korea's biopharmaceutical contract development and manufacturing organization (CDMO) company, announced on Sunday that it has...
Apr 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Kolon Pharma to merge with anti-cancer drug developer Platbio
Kolon Pharma, the pharmaceutical affiliate of South Korea's Kolon Group, is merging with anti-cancer drug developer Platbio to advance the developme...
Mar 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's CJ Bioscience buys drug candidates from 4D pharma of the UK
South Korea’s pharmaceutical and healthcare company CJ Bioscience Inc. has acquired drug candidates from the UK's 4D pharma plc. to improve co...
Mar 27, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma receives 1st overseas patent for its hair loss treatment
JW Pharmaceutical, a drug company based in South Korea, has received its first patent for a hair loss treatment that is currently in development. Th...
Mar 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong wins approval for GERD treatment Fexuclu in Chile
South Korean pharmaceutical company Daewoong Pharmaceutical announced on Tuesday that it has received marketing authorization from Chile's National ...
Mar 14, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma to develop mRNA flu vaccine with Canadian pharma
South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The dr...
Mar 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong’s Nabota expands into Germany, Austria
South Korean drugmaker Daewoong Pharmaceutical Co. said on Tuesday it had launched its botulinum toxin product Nabota in Germany and Austria through i...
Mar 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's Fexuclue safe to use with aspirin: Clinical trials
Daewoong Pharmaceutical Co., a leading South Korean pharmaceutical company, has announced the successful completion of phase 1 clinical trials for...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Novel medicines poised to be Korea’s next mainstay export
South Korea, a major global generic and biosimilar medicine producer with leading names such as Samsung Biologics Co. and Celltrion Inc., has rapidl...
Feb 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's Daewoong to export diabetes drug Envlo to Brazil, Mexico
South Korea’s Daewoong Pharmaceutical Co. said on Feb. 24 it is set to embark on global sales of Envlo, a new drug for diabetes, by exportin...
Feb 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Korean court rules Daewoong poached Medytox’s botox strain
A South Korean court on Friday ruled in favor of Medytox Inc. in a civil lawsuit against its crosstown rival Daewoong Pharmaceutical Co. over the so...
Feb 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma wins permission from Singapore for Nabota
South Korea's drug development company Daewoong Pharmaceutical said on Thursday that it received on Jan. 20 product approval for its botulinum toxin...
Feb 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Medytox to sell off 2.2 mn shares of Daewoong's American partner Evolus
Medytox Inc. said in a regulatory filing on Wednesday that it is selling off approximately 2.19 million shares of Evolus, Daewoong Pharmaceutical's ...
Feb 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong receives approval for its GERD drug Fexuclue in Ecuador
Daewoong Pharmaceutical said Friday that it has obtained marketing authorization from Ecuador's National Agency for Health Regulation, Control and S...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's botulinum toxin Nabota proves long-lasting effect
Daewoong Pharmaceutical said on Friday that a high-dose administration of botulinum toxin Nabota (US brand name: Jeuveau) to patients with frown wri...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Daewoong Pharmaceutical to export tech to British company
South Korea's Daewoong Pharmaceutical has licensed a new drug candidate for idiopathic pulmonary fibrosis (IPF) to CS Pharmaceuticals (CSP) of the U...
Feb 01, 2023 (Gmt+09:00)